URSO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 758
EU - Europa 265
AS - Asia 174
OC - Oceania 1
Totale 1.198
Nazione #
US - Stati Uniti d'America 752
IT - Italia 97
SG - Singapore 61
CN - Cina 59
TR - Turchia 36
DE - Germania 35
GB - Regno Unito 27
SE - Svezia 27
BE - Belgio 22
FI - Finlandia 22
UA - Ucraina 12
ID - Indonesia 10
PL - Polonia 8
CA - Canada 5
VN - Vietnam 5
LT - Lituania 4
CZ - Repubblica Ceca 3
FR - Francia 3
JP - Giappone 2
AT - Austria 1
AU - Australia 1
EE - Estonia 1
HK - Hong Kong 1
HU - Ungheria 1
IE - Irlanda 1
LU - Lussemburgo 1
PA - Panama 1
Totale 1.198
Città #
Fairfield 109
Woodbridge 102
Ann Arbor 72
Ferrara 58
Singapore 55
Chandler 54
Santa Clara 53
Ashburn 48
Houston 40
Seattle 39
Cambridge 35
Wilmington 26
Brussels 22
Helsinki 20
New York 20
Jacksonville 19
Izmir 14
Beijing 13
Munich 12
Nanjing 12
Shanghai 12
Princeton 11
Addison 10
Bremen 10
Jakarta 10
Milan 10
Warsaw 8
Boardman 7
Dong Ket 5
Parma 5
San Diego 5
Shenyang 4
Tianjin 4
Toronto 4
Brno 3
Bologna 2
London 2
Ningbo 2
Redmond 2
Rome 2
Traversetolo 2
Acton 1
Anzola Dell'emilia 1
Berlin 1
Cattolica 1
Changsha 1
Des Moines 1
Dongguan 1
Dublin 1
Edinburgh 1
Falkenstein 1
Falls Church 1
Frankfurt am Main 1
Hebei 1
Hong Kong 1
Hounslow 1
Jinan 1
Kunming 1
Los Angeles 1
Luxembourg 1
Nanchang 1
Norwalk 1
Orange 1
Ottawa 1
Qingdao 1
Sopron 1
Tallinn 1
Trieste 1
Vienna 1
Wuhu 1
Totale 972
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 193
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 140
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 135
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 129
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 117
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 109
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 85
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 72
Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case report 62
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency 26
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era 17
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs 11
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study 6
Totale 1.232
Categoria #
all - tutte 6.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 0 27 28 18 26 12 7 7
2020/2021182 4 23 13 11 4 9 18 14 6 49 14 17
2021/2022154 8 8 5 8 9 7 32 11 3 6 21 36
2022/2023138 13 16 9 18 17 25 11 6 16 0 4 3
2023/202493 6 9 2 2 11 27 3 6 1 2 1 23
2024/2025206 13 10 35 34 56 58 0 0 0 0 0 0
Totale 1.232